RETINAL DEGENERATION FUND
Retinal Degeneration Fund helps in accelerating life-changing outcomes for people with retinal degenerations through direct mission-related investments in therapeutic companies. The Retinal Degeneration Fund (RD Fund) is a not-for-profit subsidiary of the Foundation Fighting Blindness launched in 2018.
RETINAL DEGENERATION FUND
Industry:
Business Development Financial Services Therapeutics
Founded:
2018-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Font Awesome Mobile Non Scaleable Content
Similar Organizations
Metaplanet Holdings
Metaplanet Holdings is an early-stage investment firm that invests in diversified sectors.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-15 | Nacuity Pharmaceuticals | Retinal Degeneration Fund investment in Series B - Nacuity Pharmaceuticals | 16.5 M USD |
| 2022-01-05 | SalioGen Therapeutics | Retinal Degeneration Fund investment in Series B - SalioGen Therapeutics | 115 M USD |
| 2021-09-22 | Opus Genetics | Retinal Degeneration Fund investment in Seed Round - Opus Genetics | 19 M USD |
| 2021-05-18 | Vedere Bio ll | Retinal Degeneration Fund investment in Series A - Vedere Bio ll | 77 M USD |
| 2020-12-16 | Atsena Therapeutics | Retinal Degeneration Fund investment in Series A - Atsena Therapeutics | 55 M USD |
| 2020-11-09 | Stargazer Pharmaceuticals | Retinal Degeneration Fund investment in Series A - Stargazer Pharmaceuticals | 57 M USD |